BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
PKOH
Park-Ohio Holdings Corp.
PKOH has the edge over BA overall, supported by stronger modeled upside and stronger valuation.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
PKOH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
PKOH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over PKOH in the historical PE scenario, which offers more potential upside but is not a forecast.
PKOH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $19.71 | -58% |
| Forward | 13x | $46.92 | — |
| Fair | 19x | $45.91 | -2.2% |
| Current | 19x | $46.92 | — |
| Expensive | 28x | $68.52 | +46% |
Historical ranges are pointers, not guarantees.
PKOH's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over PKOH on the outlook, with more favorable profitability expectations.
PKOH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for PKOH, with profitability holding steady. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
PKOH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.68 | +50% |
| Q3 2026 | $2.45 | +49% |
| Q2 2026 | $1.87 | -6% |
| Q1 2026 | $1.67 | -26% |
| Q4 2025 | $1.70 | -29% |
| Q3 2025 | $1.64 | +32% |
| Q2 2025 | $1.99 | +43% |
| Q1 2025 | $2.25 | +150% |
| Q4 2024 | $2.40 | +287% |
PKOH has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over PKOH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
PKOH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $458.5M | +15% |
| Q2 2026 | $440.1M | +10% |
| Q1 2026 | $421M | +3.8% |
| Q4 2025 | $395M | +1.7% |
| Q3 2025 | $398.6M | -4.5% |
| Q2 2025 | $400.1M | -7.5% |
| Q1 2025 | $405.4M | -2.9% |
| Q4 2024 | $388.4M | -0.2% |
PKOH's revenue has grown year over year for four quarters in a row: $459M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +1.5 points |
| Q2 2026 | 5.6% | +0.6 points |
| Q1 2026 | 4.7% | 0 points |
| Q4 2025 | 2.5% | -1.2 points |
| Q3 2025 | 4.3% | -1.3 points |
| Q2 2025 | 5% | -0.7 points |
| Q1 2025 | 4.7% | -1.1 points |
| Q4 2024 | 3.7% | -0.8 points |
PKOH has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over PKOH on cash flow, with more consistent year-over-year improvement.
PKOH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.1M | +7.6% |
| Q2 2026 | -$1.8M | +$19.3M |
| Q1 2026 | -$20.3M | -$800K |
| Q4 2025 | $36M | +108% |
| Q3 2025 | $6.6M | +$6.7M |
| Q2 2025 | -$21.1M | -$11M |
| Q1 2025 | -$19.5M | -$16M |
| Q4 2024 | $17.3M | -20% |
PKOH's free cash flow has turned positive after five years mostly in the red: $21M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
PKOH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +100K shares |
| 1 year | +2.1% | +300K shares |
| 3 years | +13% | +1.7M shares |
| 5 years | +18% | +2.2M shares |
| Available history | +16% | +1.9M shares |
PKOH has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $2.5M |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $300,000 |
| Q3 2020 | $1.9M |
| Q2 2020 | $3.2M |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
PKOH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
PKOH has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
PKOH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 41.7 | Neutral |
PKOH's weekly RSI is 62 (neutral) and its Stochastic is 42 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over PKOH on valuation relative to its sector.
PKOH PE vs Industrials Sector
| Metric | PKOH | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 24x | 20% below |
| PE % | 51 | 58 | 7 pts below |
PKOH is trading at 19x earnings, a 20% discount to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
PKOH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.8 | 2.4% above |
| 20 week MA | $44.4 | 5.7% above |
| 50 week MA | $33.8 | 39% above |
| 100 week MA | $27.3 | 72% above |
| 200 week MA | $25.0 | 88% above |
PKOH has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
PKOH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.3 | $30.2 | -9.5% |
| 2021 | $30.2 | $21.5 | -29% |
| 2022 | $21.5 | $12.0 | -44% |
| 2023 | $12.0 | $27.0 | +125% |
| 2024 | $27.0 | $25.8 | -4.2% |
| 2025 | $25.8 | $21.1 | -18% |
| 2026 YTD | $21.1 | $46.9 | +122% |
PKOH has the edge over BA on returns for 2026, with the stronger performance.